Bioheart, Inc. to Transfer to Nasdaq Capital Market (PR New

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
Bioheart, Inc. to Transfer to Nasdaq Capital Market (PR New
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


Bioheart, Inc. today announced that it has received approval to transfer the listing of its common stock to the Nasdaq Capital Market. The Company's common stock will be transferred from The Nasdaq Global Market to The Nasdaq Capital Market at the opening of business on Wednesday, June 11, 2008.

Read more...
View user's profileSend private message
Bioheart, Inc. to Transfer to Nasdaq Capital Market (PR New
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map